drugset / Trial / NCT02757534

Domperidone for Chronic Nausea and Vomiting

NCT02757534

Expanded access No longer available Yehudith Assouline-Dayan

Summary

The purpose of this study is to provide oral domperidone to patients with gastroparesis, between the ages of 18 and 60 years of age, who have failed standard treatment. Standard therapy at the University of Iowa is eating blended foods, liquid diet, Eryped syrup (125 mg TID) 30 minutes before meals, or reglan (20 mg BID).

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Domperidone Unknown

Indications